Publisher： Guilford Publications Inc
ISSN： 1085-0295
Source： Child and Adolescent Psychopharmacology News, Vol.9, Iss.5, 2004-08, pp. : 13-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Supplement to CAPN Volume 9, Number 6, 2004
Child and Adolescent Psychopharmacology News, Vol. 9, Iss. 6, 2004-09 ,pp. :
Access to resources
Recommend
Supplement to CAPN Volume 10, Number 3, 2005
Child and Adolescent Psychopharmacology News, Vol. 10, Iss. 3, 2005-03 ,pp. :
Current Neuropharmacology Volume 9, Supplement 1, September 2011
Current Neuropharmacology, Vol. 9, Iss. 5, 2011-09 ,pp. :
Drugs & Therapy Perspectives. Volume 20 Issue 5. May 2004
Drugs & Therapy Perspectives, Vol. 20, Iss. 5, 2004-05 ,pp. :
The US FDA approved 31 new molecular entities in 2004, the highest number in 5 years
Inpharma, Vol. 1, Iss. 1471, 2005-01 ,pp. :